肺动脉高压临床诊治中应该关注的几个问题——基于《2022 ESC/ERS肺动脉高压诊治指南》与《中国肺动脉高压诊断与治疗指南(2021版)》的比较与解读

2022-10-12 首都医科大学附属北京安贞医院呼吸与危重症医学科 中国全科医学

肺动脉高压(PH)的临床与转化医学研究不断深入,促使PH相关指南不断更新。2021年1月由中华医学会呼吸病学分会与中国医师协会呼吸医师分会联合发布了《中国肺动脉高压诊断与治疗指南(2021版)》(简称

中文标题:

肺动脉高压临床诊治中应该关注的几个问题——基于《2022 ESC/ERS肺动脉高压诊治指南》与《中国肺动脉高压诊断与治疗指南(2021版)》的比较与解读

发布日期:

2022-10-12

简要介绍:

肺动脉高压(PH)的临床与转化医学研究不断深入,促使PH相关指南不断更新。2021年1月由中华医学会呼吸病学分会与中国医师协会呼吸医师分会联合发布了《中国肺动脉高压诊断与治疗指南(2021版)》(简称中国指南),结合当时的国内外研究提出了符合我国国情的很多推荐意见。2022年8月26欧洲心脏学会(ESC)与呼吸学会(ERS)联合发布了《2022 ESC/ERS肺动脉高压诊断与治疗指南》(简称ESC/ERS指南),指南内容较前进行了大量更新。本文将并结合中国指南相关内容,就ESC/ERS指南的更新点进行重点解读。 

点击查看《中国肺动脉高压诊断与治疗指南(2021版)》

点击查看《2022 ESC/ERS肺动脉高压诊断与治疗指南》

相关资料下载:
[AttachmentFileName(sort=1, fileName=肺动脉高压临床诊治中应该关注的几个问题——基于《2022 ESC_ERS肺动脉高压诊治指南》与《中国肺动脉高压诊断与治疗指南(2021版)》的比较与解读.pdf)] GetToolGuiderByIdResponse(projectId=1, id=f9cf01c002e2119b, title=肺动脉高压临床诊治中应该关注的几个问题——基于《2022 ESC/ERS肺动脉高压诊治指南》与《中国肺动脉高压诊断与治疗指南(2021版)》的比较与解读, enTitle=, guiderFrom=中国全科医学, authorId=0, author=, summary=肺动脉高压(PH)的临床与转化医学研究不断深入,促使PH相关指南不断更新。2021年1月由中华医学会呼吸病学分会与中国医师协会呼吸医师分会联合发布了《中国肺动脉高压诊断与治疗指南(2021版)》(简称, cover=https://img.medsci.cn/202201012/1665539361102_5579292.jpg, journalId=0, articlesId=null, associationId=2598, associationName=首都医科大学附属北京安贞医院呼吸与危重症医学科, associationIntro=首都医科大学附属北京安贞医院呼吸与危重症医学科, copyright=0, guiderPublishedTime=Wed Oct 12 00:00:00 CST 2022, originalUrl=, linkOutUrl=, content=<p><span style="color: #666666;">肺动脉高压(PH)的临床与转化医学研究不断深入,促使PH相关指南不断更新。2021年1月由中华医学会呼吸病学分会与中国医师协会呼吸医师分会联合发布了《中国肺动脉高压诊断与治疗指南(2021版)》(简称中国指南),结合当时的国内外研究提出了符合我国国情的很多推荐意见。2022年8月26欧洲心脏学会(ESC)与呼吸学会(ERS)联合发布了《2022 ESC/ERS肺动脉高压诊断与治疗指南》(简称ESC/ERS指南),指南内容较前进行了大量更新。本文将并结合中国指南相关内容,就ESC/ERS指南的更新点进行重点解读。&nbsp;</span></p> <p><a href="https://www.medsci.cn/guideline/show_article.do?id=d88e21c00216906a" target="_blank" rel="noopener">点击查看<span style="color: #666666;">《中国肺动脉高压诊断与治疗指南(2021版)》</span></a></p> <p><a href="https://www.medsci.cn/guideline/show_article.do?id=0b1341c00262e53c" target="_blank" rel="noopener">点击查看<span style="color: #666666;">《2022 ESC/ERS肺动脉高压诊断与治疗指南》</span></a></p>, tagList=[TagDto(tagId=1179, tagName=肺动脉高压)], categoryList=[CategoryDto(categoryId=2, categoryName=心血管, tenant=100), CategoryDto(categoryId=12, categoryName=呼吸, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=0, guiderKeyword=, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=解读, guiderLanguage=0, guiderRegion=3, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=2577, appHits=138, showAppHits=0, pcHits=596, showPcHits=2430, likes=0, shares=12, comments=2, approvalStatus=1, publishedTime=Mon Oct 17 09:48:00 CST 2022, publishedTimeString=2022-10-12, pcVisible=1, appVisible=1, editorId=0, editor=FUNNYMAN, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=6, createdBy=null, createdName=FUNNYMAN, createdTime=Wed Oct 12 09:49:47 CST 2022, updatedBy=6459136, updatedName=艺玮, updatedTime=Tue Jan 02 11:56:54 CST 2024, courseDetails=[], otherVersionGuiders=[OtherVersionToolGuiderDto(projectId=1, id=0b1341c00262e53c, title=2022 ESC/ERS肺动脉高压诊治指南, enTitle=2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension, guiderPublishedTime=Fri Aug 26 00:00:00 CST 2022, createdTime=Sun Aug 28 09:11:33 CST 2022), OtherVersionToolGuiderDto(projectId=1, id=70f4e1c002a03668, title=《中国肺动脉高压诊断与治疗指南(2021版)》解读——动脉性肺动脉高压的治疗, enTitle=, guiderPublishedTime=Tue Mar 01 00:00:00 CST 2022, createdTime=Sun Apr 03 23:27:57 CST 2022), OtherVersionToolGuiderDto(projectId=1, id=4885d1c002a03513, title=《中国肺动脉高压诊断与治疗指南(2021版)》解读——肺动脉高压中心的建设, enTitle=, guiderPublishedTime=Tue Mar 01 00:00:00 CST 2022, createdTime=Sun Apr 03 23:26:18 CST 2022), OtherVersionToolGuiderDto(projectId=1, id=359491c002a0346a, title=《中国肺动脉高压诊断与治疗指南(2021版)》解读——儿童肺动脉高压, enTitle=, guiderPublishedTime=Tue Mar 01 00:00:00 CST 2022, createdTime=Sun Apr 03 22:48:33 CST 2022), OtherVersionToolGuiderDto(projectId=1, id=12c6a1c00235e94d, title=《中国肺动脉高压诊断与治疗指南(2021版)》解读——具有明显肺静脉或肺毛细血管受累的肺动脉高压, enTitle=, guiderPublishedTime=Tue Feb 01 00:00:00 CST 2022, createdTime=Wed Feb 16 22:12:19 CST 2022), OtherVersionToolGuiderDto(projectId=1, id=f4d7e1c00235e869, title=《中国肺动脉高压诊断与治疗指南(2021版)》解读——左心疾病所致肺动脉高压, enTitle=, guiderPublishedTime=Tue Feb 01 00:00:00 CST 2022, createdTime=Wed Feb 16 22:02:57 CST 2022), OtherVersionToolGuiderDto(projectId=1, id=bfe2e1c002355527, title=《中国肺动脉高压诊断与治疗指南(2021版)》解读——结缔组织病相关肺动脉高压, enTitle=, guiderPublishedTime=Wed Dec 01 00:00:00 CST 2021, createdTime=Sun Feb 13 11:15:52 CST 2022), OtherVersionToolGuiderDto(projectId=1, id=318a71c002352e8e, title=《中国肺动脉高压诊断与治疗指南(2021版)》解读——聚焦先天性心脏病相关肺动脉高压, enTitle=, guiderPublishedTime=Fri Oct 01 00:00:00 CST 2021, createdTime=Sat Feb 12 00:10:15 CST 2022), OtherVersionToolGuiderDto(projectId=1, id=328001c002321a50, title=《中国肺动脉高压诊断与治疗指南(2021版)》解读——肺部疾病和(或)低氧所致肺动脉高压, enTitle=, guiderPublishedTime=Sat Jan 01 00:00:00 CST 2022, createdTime=Sat Jan 15 21:45:13 CST 2022), OtherVersionToolGuiderDto(projectId=1, id=d88e21c00216906a, title=中国肺动脉高压诊断与治疗指南(2021版) , enTitle=, guiderPublishedTime=Tue Jan 05 00:00:00 CST 2021, createdTime=Tue Aug 31 23:47:15 CST 2021)], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=肺动脉高压临床诊治中应该关注的几个问题——基于《2022 ESC_ERS肺动脉高压诊治指南》与《中国肺动脉高压诊断与治疗指南(2021版)》的比较与解读.pdf)])
肺动脉高压临床诊治中应该关注的几个问题——基于《2022 ESC_ERS肺动脉高压诊治指南》与《中国肺动脉高压诊断与治疗指南(2021版)》的比较与解读.pdf
下载请点击:
评论区 (2)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=2103867, encodeId=9f11210386eac, content=打卡, beContent=null, objectType=guider, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=43718258358, createdName=ms3000002106324246, createdTime=Fri Dec 02 10:04:17 CST 2022, time=2022-12-02, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2103311, encodeId=0a02210331143, content=感谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=43718258358, createdName=ms3000002106324246, createdTime=Tue Nov 29 14:48:39 CST 2022, time=2022-11-29, status=1, ipAttribution=四川省)]
    2022-12-02 ms3000002106324246 来自四川省

    打卡

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=2103867, encodeId=9f11210386eac, content=打卡, beContent=null, objectType=guider, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=43718258358, createdName=ms3000002106324246, createdTime=Fri Dec 02 10:04:17 CST 2022, time=2022-12-02, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2103311, encodeId=0a02210331143, content=感谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=43718258358, createdName=ms3000002106324246, createdTime=Tue Nov 29 14:48:39 CST 2022, time=2022-11-29, status=1, ipAttribution=四川省)]
    2022-11-29 ms3000002106324246 来自四川省

    感谢分享

    0